Journal of Hypertension

Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage.  41:288-294. 2023

Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy.  40:1597-1606. 2022

BMI and blood pressure control among United States adults with hypertension.  40:741-748. 2022

Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age.  40:94-101. 2022

The association of actigraphy-assessed sleep duration with sleep blood pressure, nocturnal hypertension, and nondipping blood pressure: the coronary artery risk development in young adults (CARDIA) study.  39:2478-2487. 2021

Sustained SBP control and long-term nursing home admission among Medicare beneficiaries.  39:2258-2264. 2021

In Memoriam: Jiří Widimský Sr. 1925-2020..  39:386-388. 2021

Obstructive sleep apnea ismore severe inmen but not womenwith refractory hypertension comparedwith controlled resistant hypertension.  39:286-291. 2021

In memoriam: Peter Sleight 1929-2020..  38:2546-2548. 2020

Disregard the reported data from the HYGIA project: blood pressure medication not to be routinely dosed at bedtime.  38:2144-2145. 2020

Blood pressure medication should not be routinely dosed at bedtime. We must disregard the data from the HYGIA project. 2020

Circadian variations in blood pressure and their implications for the administration of antihypertensive drugs: Is dosing in the evening better than in the morning?.  38:1396-1406. 2020

Associations of awake and asleep blood pressure and blood pressure dipping with abnormalities of cardiac structure: The Coronary Artery Risk Development in Young Adults study.  38:102-110. 2020

Sex differences in masked hypertension: The Coronary Artery Risk Development in Young Adults study.  37:2380-2388. 2019

Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study.  37:2216-2224. 2019

Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: Data from the Coronary Artery Risk Development in Young Adults study.  37:1401-1410. 2019

Reply.  36:1423-1424. 2018

Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrial.  36:904-915. 2018

What is the most appropriate target SBP in persons with hypertension and diabetes mellitus?.  36:37-40. 2018

Should sleep blood pressure be used as a criterion to define white-coat hypertension?.  35:2372-2373. 2017

Associations of blood pressure, sunlight, and Vitamin D in community-dwelling adults.  34:1704-1710. 2016

OS 24-04 A PILOT STUDY ASSESSING THE FEASIBILITY OF VASCULAR FUNCTION IN LOW SOCIOECONOMIC STATUS PRESCHOOL CHILDREN..  34 Suppl 1:e244. 2016

OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX..  34 Suppl 1:e393. 2016

OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX..  34 Suppl 1 - ISH 2016 Abstract Book:e393. 2016

SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?.  34 Suppl 1:e366. 2016

SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?.  34 Suppl 1 - ISH 2016 Abstract Book:e366. 2016

Is white-coat hypertension associated with increased cardiovascular and mortality risk?.  34:1655-1658. 2016

Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT).  34:1224-1231. 2016

Urinary sodiumexcretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.  34:1005-1010. 2016

Continued increases in hypertension over three decades in Fiji, and the influence of obesity.  34:402-409. 2016

Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study.  34:235-243. 2016

Effects of pentoxifylline on inflammatorymarkers and blood pressure: A systematic reviewandmeta-analysis of randomized controlled trials.  34:2318-2329. 2016

Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?.  33:1108-1113. 2015

Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: The Cohort Study of Medication Adherence among Older Adults (CoSMO).  33:412-420. 2015

Particulate matter air pollution and ambient temperature: Opposing effects on blood pressure in high-risk cardiac patients.  33:2032-2038. 2015

Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function.  32:174-180. 2014

Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease.  32:2479-2487. 2014

The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: Results from a multicenter randomized controlled trial.  32:840-848. 2014

High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans.  31:530-536. 2013

The contributions of unhealthy lifestyle factors to apparent resistant hypertension: Findings from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  31:370-376. 2013

Hypertension and orthostatic hypotension in older patients.  30:38-39. 2012

Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study.  30:1233-1240. 2012

Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.  29:161-170. 2011

Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care.  29:2332-2338. 2011

The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension.  29:1829-1836. 2011

Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.  29:1810-1819. 2011

Blood pressure and hypertension in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama..  28:2053-2060. 2010

Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.  28:2076-2083. 2010

Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: The Losartan Intervention for Endpoint reduction in hypertension study.  27:567-574. 2009

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.  27:673-679. 2009

Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.  26:1360-1366. 2008

Pathogenesis of essential hypertension: Historical paradigms and modern insights.  26:381-391. 2008

Aldosterone excess and resistance to 24-h blood pressure control.  25:2131-2137. 2007

Glcosamine inhibits inflammatory response to tumor necrosis factor-alpha in vascular smooth muscle cells via augmentation of protein O-GlcNAcylation.  24:179-180. 2006

Hypertension after experimental cerebral ischemia: Candesartan provides neurovascular protection.  24:535-539. 2006

Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.  24:2255-2261. 2006

Vascular and metabolic effects of candesartan: Insights from therapeutic interventions.  24. 2006

Diuretic-induced hyperuricemia does not decrease cardiovascular risk..  22:1415-1417. 2004

Diuretic-induced hyperuricemia does not decrease cardiovascular risk [2] (multiple letters).  22:1415-1419. 2004

Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.  22:1805-1811. 2004

Effect of dietary fiber intake on blood pressure: A randomized, double-blind, placebo-controlled trial.  22:73-80. 2004

Elevated arterial pressure impairs autoregulation independently of AT 1 receptor activation.  22:811-818. 2004

Comparison of the SCOPE and LIFE results [2] (multiple letters).  21:1772-1773. 2003

Comparison of the SCOPE and LIFE results..  21:1772-1773. 2003

Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization.  21:1157-1162. 2003

Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization..  21:1157-1162. 2003

Transgenic study of the function of chymase in heart remodeling.  20:2047-2055. 2002

Decreased endothelin binding and [Ca²⁺]i signaling in microvessels of DOCA-salt hypertensive rats.  20:1799-1805. 2002

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.  20:1879-1886. 2002

Enalaprilat blunts reflexive increases in cardiac interstitial norepinephrine in conscious rats.  19:2025-2029. 2001

Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects.  19:1745-1754. 2001

What do international guidelines say about therapy?.  19. 2001

Interaction between lifetime captopril treatment and NaCl-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.  17:983-991. 1999

Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA Study): influence of a family history of hypertension. Coronary Artery Risk Development in Young Adults..  15:955-962. 1997

Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA study): Influence of a family history of hypertension.  15:955-962. 1997

Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats.  13:1037-1042. 1995

Ethnic differences in angiotensin converting enzyme gene polymorphism.  13:710-711. 1995

Muscle sympathetic nervous system activity in black and caucasian hypertensive subjects.  12:1291-1296. 1994

Atrial natriuretic peptide inhibits sympathetic outflow in NaCi-sensitive spontaneously hypertensive rats.  9:1177-1185. 1991

Dietary ca²⁺ increases natriuretic and diuretic responses to volume loading in nacl-sensitive spontaneously hypertensive rats.  8:947-951. 1990

Dietary ca²⁺ prevents naci-induced exacerbation of hypertension and increases hypothalamic norepinephrine turnover in spontaneously hypertensive rats.  7:711-719. 1989

Hypothalamic microinjection of alpha2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets.  6:805-813. 1988

The use of complementary peptides in the purification of an angiotensin II binding protein.  6:S404-S407. 1988

Prediction of response to sodium intervention for blood pressure control.  4. 1986

Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.  2:63-66. 1984

Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat..  2:S63-S66. 1984

Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH).  2:179-181. 1984

Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension..  2:S179-S181. 1984